vimarsana.com

Page 4 - Clearpoint Neuro Navigation System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ClearPoint Neuro Reports Third Quarter 2023 Results

SOLANA BEACH, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platfor.

United statesSolana beachJoe burnettCompany investorApplications of the companyClearpoint navigation softwareClearpoint neuro incCompany quarterly report on formExchange commissionCompany annual report on formPoint neuroMaestro brain modelQuarter ended septemberBrain computer interfaceClearpoint neuro navigation systemNorth america

ClearPoint Neuro, Inc : ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that

United statesJeremy stigallDhaval patelGewinn nurCompany quarterly report on formCompany annual report on formCompany clearpoint neuro navigation systemExchange commission onExchange commissionClearpoint neuro incApplications of the companyPoint neuroExecutive vice presidentGeneral managerDrug deliveryClearpoint neuro

| Polska Agencja Prasowa SA

Polska Agencja Prasowa SA, Polish Press Agency

United statesJeremy stigallDhaval patelJacqueline kellerExchange commissionCompany quarterly report on formClearpoint neuro incCompany clearpoint neuro navigation systemCompany annual report on formApplications of the companyExchange commission onPoint neuroExecutive vice presidentGeneral managerDrug deliveryClearpoint neuro

ClearPoint Neuro to Present at the B Riley Securities 2023

SOLANA BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company.

United statesDanilo dalessandroApplications of the companyClearpoint neuro incPoint neuroInvestor conferenceClearpoint neuro navigation systemNorth americaClearpoint neuroPoint neuro contactChief financialNasdaq clptClearpoint neuro

ClearPoint Neuro to Present Investigational Research and

SOLANA BEACH, Calif., May 10, 2023 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company.

United statesLos angelesJeremy stigallCompany quarterly report on formAmerican society of geneCompany annual report on formClearpoint neuro incCompany clearpoint neuro navigation systemApplications of the companyExchange commissionPoint neuroAmerican societyCell therapyPoster sessionExhibitor showcaseTargeted gene delivery

vimarsana © 2020. All Rights Reserved.